Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregg Zoarski

Diagnostic Radiology Tampa, FL Medical Doctor

NPI 1215929948 CMS profile 236041

1 Tampa General Cir, Tampa, FL 33606

Open in the dashboard

General payments

$4,787

116 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$34,402 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Gregg Zoarski of Tampa, FL is reported in the CMS Open Payments database as having received $4,787 across 116 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $34,402 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $613 22
2024 General $926 21
2023 General $468 8
2022 General $513 14
2021 General $584 12
2020 General $792 16
2019 General $891 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregg Zoarski
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Gregg Zoarski were reported at $613. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Gregg Zoarski Diagnostic Radiology median Middle half National median
2019 $891 $108 $29–$318 $163
2020 $792 $65 $21–$252 $114
2021 $584 $92 $24–$292 $132
2022 $513 $104 $29–$294 $149
2023 $468 $110 $29–$337 $160
2024 $926 $113 $30–$356 $164
2025 $613 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Sales Inc. $1,601 45 payments
  2. Stryker Corporation $970 22 payments
  3. Penumbra, Inc. $582 10 payments
  4. Balt USA, LLC $339 5 payments
  5. Route 92 Medical, Inc. $261 3 payments
  6. Imperative Care, INc $213 9 payments
  7. Rapid Medical LTD $203 4 payments
  8. Kaneka Pharma America LLC $181 1 payment
  9. MicroVention, Inc. $138 5 payments
  10. Medtronic USA, Inc. $86 2 payments
  11. Other $215 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,787 116 payments
Products named General payments · program years 2019–2025
  1. EMBOTRAP $395 13 payments
  2. CEREPAK UNIFORM $394 16 payments
  3. Penumbra System Neurointervention $362 7 payments
  4. Spectra $354 7 payments
  5. EMBOTRAP II Revascularization Device $353 6 payments
  6. Optima Coil System $299 4 payments
  7. Penumbra System Neurointervention $220 3 payments
  8. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $203 4 payments
  9. COMANECI 17 $203 4 payments
  10. SURPASS $197 3 payments
  11. Other $1,825 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$29,671

Medicare's payments for the services billed

Medicare patients

160

Average age 72

Services billed

273

80 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 47%
Chronic kidney disease 42%
Diabetes 41%
Atrial fibrillation 41%
Depression 41%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record